TY  - GEN
AU  - Opal,S M
AU  - Cross,A S
AU  - Jhung,J W
AU  - Young,L D
AU  - Palardy,J E
AU  - Parejo,N A
AU  - Donsky,C
TI  - Potential hazards of combination immunotherapy in the treatment of experimental septic shock
SN  - 0022-1899
PY  - 1996///0725
KW  - Animals
KW  - Bacteremia
KW  - blood
KW  - Carrier Proteins
KW  - adverse effects
KW  - Colony Count, Microbial
KW  - Cyclophosphamide
KW  - pharmacology
KW  - Drug Therapy, Combination
KW  - Endotoxins
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Immunotherapy
KW  - Interleukin 1 Receptor Antagonist Protein
KW  - Interleukin-1
KW  - Neutropenia
KW  - chemically induced
KW  - Polyethylene Glycols
KW  - chemistry
KW  - Pseudomonas Infections
KW  - pathology
KW  - Pseudomonas aeruginosa
KW  - growth & development
KW  - Rats
KW  - Receptors, Tumor Necrosis Factor
KW  - Receptors, Tumor Necrosis Factor, Type I
KW  - Recombinant Proteins
KW  - Shock, Septic
KW  - Sialoglycoproteins
KW  - Tumor Necrosis Factor Decoy Receptors
KW  - Tumor Necrosis Factor-alpha
KW  - analysis
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/infdis/173.6.1415
ER  -